JNJ · Healthcare · Drug Manufacturers - General
Johnson & Johnson’s 54.9M-share high tests the limit of an unconfirmed advance
JNJ jumped 11.5% to finish just 0.2% below its 52-week high, but negative activity pressure and a 52% Fair Value premium keep the weekly setup from being one-sided.
254.7 USDLatest Close
11.5%1W Return
13.0%4W Return
5.4%12W Return